New strategy can help determine heart attack in patients within one hour

A new strategy to rule-out and rule-in heart attacks in emergency departments will help physicians treat patients faster, found a clinical trial published in CMAJ (Canadian Medical Association Journal).

Acute myocardial infarction (MI) is a common cause of death and disability around the world. Early diagnosis is critical for treatment and survival.

Swiss and Spanish researchers conducted a clinical trial to determine whether a new technique, previously tested in a small pilot study, would be effective in determining whether a patient has had a . They enrolled 1320 patients who visited the with suspected acute MI and applied the high-sensitivity cardiac troponin T 1-hour algorithm to blood samples.

"Introducing the high-sensitivity cardiac troponin T 1-hour algorithm into clinical practice would represent a profound change and it is therefore important to determine if it works in a large patient group," states Dr. Tobias Reichlin, Division of Cardiology, University Hospital Basel, Switzerland.

With the algorithm, the researchers were able to determine that 786 (60%) of patients did not have an acute MI ("rule-out"), 216 (16%) were "rule-in" and 318 (24%) were to be observed because results were not conclusive.

"This rapid strategy incorporating high-sensitivity cardiac troponin T baseline values and absolute changes after the first hour substantially accelerates the management of patients with suspected acute MI by allowing safe rule-out as well as accurate rule-in of acute MI in 3 out of 4 patients," the authors conclude.


Explore further

Strategy appears to help rule-in, rule-out heart attack within one hour

More information: Canadian Medical Association Journal, www.cmaj.ca/lookup/doi/10.1503/cmaj.141349
Citation: New strategy can help determine heart attack in patients within one hour (2015, April 13) retrieved 2 June 2020 from https://medicalxpress.com/news/2015-04-strategy-heart-patients-hour.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
9 shares

Feedback to editors

User comments